Claire Dossier

2.0k total citations
42 papers, 571 citations indexed

About

Claire Dossier is a scholar working on Nephrology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Claire Dossier has authored 42 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Nephrology, 11 papers in Pathology and Forensic Medicine and 10 papers in Hematology. Recurrent topics in Claire Dossier's work include Renal Diseases and Glomerulopathies (25 papers), Autoimmune Bullous Skin Diseases (9 papers) and Platelet Disorders and Treatments (5 papers). Claire Dossier is often cited by papers focused on Renal Diseases and Glomerulopathies (25 papers), Autoimmune Bullous Skin Diseases (9 papers) and Platelet Disorders and Treatments (5 papers). Claire Dossier collaborates with scholars based in France, Canada and Italy. Claire Dossier's co-authors include Georges Deschênes, Julien Hogan, Agnès Jamin, Véronique Baudouin, Thérèsa Kwon, Anne Maisin, Julien Gautherot, Chantal Housset, Anne‐Marie Durand‐Schneider and Tounsia Aït‐Slimane and has published in prestigious journals such as Hepatology, Kidney International and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Claire Dossier

39 papers receiving 565 citations

Peers

Claire Dossier
Haresh Selvaskandan United Kingdom
Alexis Harris United States
Anne M. Durkan Australia
Christian Brown United Kingdom
E. N. Griep Netherlands
Claire Dossier
Citations per year, relative to Claire Dossier Claire Dossier (= 1×) peers R. Confalonieri

Countries citing papers authored by Claire Dossier

Since Specialization
Citations

This map shows the geographic impact of Claire Dossier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Dossier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Dossier more than expected).

Fields of papers citing papers by Claire Dossier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Dossier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Dossier. The network helps show where Claire Dossier may publish in the future.

Co-authorship network of co-authors of Claire Dossier

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Dossier. A scholar is included among the top collaborators of Claire Dossier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Dossier. Claire Dossier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joly, Bérangère S., Adrien Joseph, Pierre Boisseau, et al.. (2025). Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura. Blood Advances. 10(5). 1831–1842.
2.
Dossier, Claire & Julien Hogan. (2025). Evidence supporting the use of anti-CD20 as first-line steroid-sparing agent in childhood nephrotic syndrome. Kidney International. 108(4). 537–541.
3.
Kwon, Thérèsa, Claire Dossier, Véronique Baudouin, et al.. (2024). IgG-immunoadsorptions and eculizumab combination in STEC-hemolytic and uremic syndrome pediatric patients with neurological involvement. Pediatric Nephrology. 40(2). 431–440. 1 indexed citations
4.
Donadelli, Roberta, Claire Dossier, Thérèsa Kwon, et al.. (2024). Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?. Pediatric Nephrology. 39(11). 3263–3269. 1 indexed citations
5.
Cambier, Alexandra, Jean‐Philippe Roy, Claire Dossier, et al.. (2023). IgA nephropathy in children with minimal proteinuria: to biopsy or not to biopsy?. Pediatric Nephrology. 39(3). 781–787. 1 indexed citations
6.
Berthaud, Romain, Claire Dossier, Jean‐Daniel Delbet, et al.. (2023). Renal vein thrombosis in neonates: a case series of diagnosis, treatment and childhood kidney function follow-up. Pediatric Nephrology. 38(9). 3055–3063. 3 indexed citations
7.
Veltkamp, Floor, Hessel Peters‐Sengers, Jesper Kers, et al.. (2023). Incidence of idiopathic nephrotic syndrome during the Covid-19 pandemic in the Paris area (France) and in the Netherlands. Pediatric Nephrology. 38(11). 3681–3692. 4 indexed citations
8.
Cambier, Alexandra, Claire Dossier, Julien Hogan, et al.. (2022). Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case. Pediatric Nephrology. 37(7). 1597–1603. 3 indexed citations
9.
Maroni, A., et al.. (2022). Malignant arterial hypertension in a 2-month-old girl: Etiological diagnosis and treatment. Archives de Pédiatrie. 29(7). 537–539. 1 indexed citations
10.
Chan, Eugene Yu-hin, Hazel Webb, E. Yu, et al.. (2019). Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes. Kidney International. 97(2). 393–401. 66 indexed citations
11.
Deschênes, Georges, Claire Dossier, & Julien Hogan. (2018). Treating the idiopathic nephrotic syndrome: are steroids the answer?. Pediatric Nephrology. 34(5). 777–785. 6 indexed citations
12.
Hogan, Julien, et al.. (2018). Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study. Pediatric Nephrology. 33(9). 1513–1521. 15 indexed citations
13.
Hogan, Julien, Claire Dossier, Thérèsa Kwon, et al.. (2018). Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome. Pediatric Nephrology. 34(2). 253–259. 33 indexed citations
14.
Boyer, Olivia, Véronique Baudouin, E. Bérard, et al.. (2017). Aspects cliniques du syndrome néphrotique idiopathique de l’enfant. Archives de Pédiatrie. 24(12). 1338–1343. 6 indexed citations
15.
Roelens, Marie, Claire Dossier, Odile Fenneteau, Nathalie Couque, & Lydie Da Costa. (2016). Glucose-6-phosphate dehydrogenase deficiency: the added value of cytology. Annales de biologie clinique. 74(3). 299–305. 2 indexed citations
16.
Hogan, Julien, Claire Dossier, Marc Fila, et al.. (2016). Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome. Pediatric Nephrology. 31(11). 2095–2101. 10 indexed citations
17.
Dossier, Claire, Agnès Jamin, & Georges Deschênes. (2016). Idiopathic nephrotic syndrome: the EBV hypothesis. Pediatric Research. 81(1-2). 233–239. 29 indexed citations
18.
Dossier, Claire, Nathanaël Lapidus, Florian Bayer, et al.. (2016). Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic?. Pediatric Nephrology. 31(12). 2299–2308. 31 indexed citations
19.
Fila, Marc, Anne Maisin, Claire Dossier, et al.. (2015). Comparison between valganciclovir and aciclovir/valaciclovir for CMV prophylaxis in pediatric renal transplantation. Saudi Journal of Kidney Diseases and Transplantation. 26(3). 453–453. 7 indexed citations
20.
Dossier, Claire, Anne‐Laure Sellier‐Leclerc, Alexandra Rousseau, et al.. (2014). Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome. Pediatric Nephrology. 29(12). 2325–2331. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026